Evidence map›Paper›PMID 31745667›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2020

Comparison of Al

Yongkang Gai, Lujie Yuan, Lingyi Sun, Huiling Li, Mengting Li, Hanyi Fang, Bouhari Altine, Qingyao Liu, Yongxue Zhang, Dexing Zeng and 1 more

Open access · greenAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.European journal of nuclear medicine and molecular imaging · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Yongkang GaiDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Lujie YuanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Lingyi SunCenter for Radiochemistry Research, Department of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, 97239, USA.
Huiling LiDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Mengting LiDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Hanyi FangDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Bouhari AltineDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Qingyao LiuDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Yongxue ZhangDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Dexing ZengCenter for Radiochemistry Research, Department of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, 97239, USA. zengd@ohsu.edu.
Xiaoli LanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. LXL730724@hotmail.com.
State Key Laboratory of Information Engineering in Surveying Mapping and Remote Sensing · CNHuazhong University of Science and Technology · CNOregon Health & Science University · USUnion Hospital · CN

Funding

Novel Platform to achieve high avidity of heterodimers for targeted cancer imagingR21EB020737 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZENG, DEXING · 2015 to 2016
$424k
NIBIB NIH HHS R21 EB020737
6 · The paper itself

Abstract

Malignant melanoma is an aggressive cancer with poor prognosis. Very late antigen-4 (VLA-4) is overexpressed in melanoma and many other tumors, making it an attractive target for developing molecular diagnostic and therapeutic agents. We compared Al

Indexed as

AnimalsDipeptidesFluorine RadioisotopesGallium RadioisotopesHeterocyclic Compounds, 1-RingHumansIntegrin alpha4beta1MelanomaMicePhenylurea CompoundsPolyethylene GlycolsPositron-Emission TomographySkin NeoplasmsXenograft Model Antitumor Assays1,4,7-triazacyclononane-N,N',N''-triacetic acid15-amino-4,7,10,13-tetraoxapentadecanoic acidDipeptidesFluorine RadioisotopesGallium RadioisotopesHeterocyclic Compounds, 1-RingIntegrin alpha4beta1LLP2A compoundPhenylurea CompoundsPolyethylene Glycols68GaAl18F radiolabelingLLP2AMelanomaPET imagingVLA-4

Identifiers

PMID31745667
PMCPMC7067668
OpenAlexW2991406598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.